Evidence map›Paper›PMID 39662356›Full record

SynthesisDrug and alcohol dependence2025

Patient and provider experiences with opioid use disorder care delivered via telehealth: A systematic mixed-studies review.

Shoshana V Aronowitz, Naomi Zucker, Morgan Thompson, Richard James, Justin Clapp, David Mandell

Abstract readSystematic Review
In one paragraph

Synthesis in Drug and alcohol dependence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shoshana V AronowitzUniversity of Pennsylvania School of Nursing, Philadelphia, PA, USA. Electronic address: visho@nursing.upenn.edu.
Naomi ZuckerUniversity of Pennsylvania School of Arts and Sciences, Philadelphia, PA, USA.
Morgan ThompsonUniversity of Pennsylvania School of Nursing, Philadelphia, PA, USA.
Richard JamesNemours Children's Health, Wilmington, DE, USA.
Justin ClappUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
David MandellUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Funding

Improving access to opioid use disorder treatment among marginalized patients with a tailored telehealth interventionK23DA057528 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI Shoshana V. Aronowitz · 2023 to 2026
$855k
NIDA NIH HHS K23 DA057528
6 · The paper itself

Abstract

introductionSince the onset of the COVID-19 pandemic and loosening of some opioid use disorder (OUD) treatment regulations in the U.S. and Canada, there has been a rapid rise in the use of telehealth for buprenorphine induction, maintenance, and counseling (tele-bupe). Previous reviews highlight that tele-bupe can expand access to OUD care and improve treatment retention, but none to date have synthesized patient and clinician experiences with and perceptions of this care.

objectiveThis review synthesized findings from quantitative, qualitative, and mixed-methods studies that examined patient and provider experiences with tele-bupe. We assessed the perceived effectiveness and acceptability of this treatment modality.

methodsOur systematic review followed PRISMA 2020 guidelines. In July 2023, we searched six databases using keywords 'telehealth AND opioid use disorder' (and related terms) for papers published in English. Papers were eligible for inclusion if they reported findings about patient or provider experiences. Two reviewers screened studies for inclusion; 40 studies were included. We used a data-based convergent synthesis design to extract and synthesize findings, and the Mixed-Methods Appraisal Tool to appraise studies.

resultsPatients and providers hold generally positive views of tele-bupe and most support its continued use in some form, citing multiple benefits, including accessibility and convenience. Most studies also identified barriers to tele-bupe, including technological challenges. Patients and providers differed in how they thought telehealth affects the clinical relationship, with providers expressing more concern about rapport-building and patients stating that being in their own environments during visits facilitated comfort and openness. The findings also suggest that providers are conflicted about when and for whom tele-bupe is appropriate.

conclusionOverall, both patients and providers view tele-bupe favorably; however, providers are conflicted about the patients and situations for which it is appropriate, which may lead to inequities in who is offered this form of care.

Indexed as

BuprenorphineCOVID-19Opiate Substitution TreatmentOpioid-Related DisordersTelemedicineHumansBuprenorphine(3–6 keywords) telemedicineBuprenorphineMedications for opioid use disorderOpioid-use disorderPatient and provider experiencesTreatment access

Identifiers

PMID39662356
PMCPMC11685034

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.